312 related articles for article (PubMed ID: 20810785)
1. Effects of selenite and chelating agents on mammalian thioredoxin reductase inhibited by mercury: implications for treatment of mercury poisoning.
Carvalho CM; Lu J; Zhang X; Arnér ES; Holmgren A
FASEB J; 2011 Jan; 25(1):370-81. PubMed ID: 20810785
[TBL] [Abstract][Full Text] [Related]
2. Mercury and selenium interaction in vivo: effects on thioredoxin reductase and glutathione peroxidase.
Branco V; Canário J; Lu J; Holmgren A; Carvalho C
Free Radic Biol Med; 2012 Feb; 52(4):781-93. PubMed ID: 22198265
[TBL] [Abstract][Full Text] [Related]
3. Molecular bases of thioredoxin and thioredoxin reductase-mediated prooxidant actions of (-)-epigallocatechin-3-gallate.
Zhang H; Cao D; Cui W; Ji M; Qian X; Zhong L
Free Radic Biol Med; 2010 Dec; 49(12):2010-8. PubMed ID: 20951799
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous administration of sodium selenite and mercuric chloride decreases efficacy of DMSA and DMPS in mercury elimination in rats.
Juresa D; Blanusa M; Kostial K
Toxicol Lett; 2005 Jan; 155(1):97-102. PubMed ID: 15585364
[TBL] [Abstract][Full Text] [Related]
5. Selenite incubated with NADPH and mammalian thioredoxin reductase yields selenide, which inhibits lipoxygenase and changes the electron spin resonance spectrum of the active site iron.
Björnstedt M; Odlander B; Kuprin S; Claesson HE; Holmgren A
Biochemistry; 1996 Jul; 35(26):8511-6. PubMed ID: 8679612
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
Li S; Zhang J; Li J; Chen D; Matteucci M; Curd J; Duan JX
Biol Trace Elem Res; 2010 Sep; 136(3):294-301. PubMed ID: 19838642
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the human thioredoxin system. A molecular mechanism of mercury toxicity.
Carvalho CM; Chew EH; Hashemy SI; Lu J; Holmgren A
J Biol Chem; 2008 May; 283(18):11913-23. PubMed ID: 18321861
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro inhibition of mice thioredoxin reductase by methylmercury.
Wagner C; Sudati JH; Nogueira CW; Rocha JB
Biometals; 2010 Dec; 23(6):1171-7. PubMed ID: 20717703
[TBL] [Abstract][Full Text] [Related]
9. The role of thioredoxin reductase activity in selenium-induced cytotoxicity.
Madeja Z; Sroka J; Nyström C; Björkhem-Bergman L; Nordman T; Damdimopoulos A; Nalvarte I; Eriksson LC; Spyrou G; Olsson JM; Björnstedt M
Biochem Pharmacol; 2005 Jun; 69(12):1765-72. PubMed ID: 15935149
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity.
Lu J; Papp LV; Fang J; Rodriguez-Nieto S; Zhivotovsky B; Holmgren A
Cancer Res; 2006 Apr; 66(8):4410-8. PubMed ID: 16618767
[TBL] [Abstract][Full Text] [Related]
11. Synergism between thioredoxin reductase inhibitor ethaselen and sodium selenite in inhibiting proliferation and inducing death of human non-small cell lung cancer cells.
Zheng X; Xu W; Sun R; Yin H; Dong C; Zeng H
Chem Biol Interact; 2017 Sep; 275():74-85. PubMed ID: 28757135
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the thioredoxin system in the brain and liver of zebra-seabreams exposed to waterborne methylmercury.
Branco V; Canário J; Holmgren A; Carvalho C
Toxicol Appl Pharmacol; 2011 Mar; 251(2):95-103. PubMed ID: 21168431
[TBL] [Abstract][Full Text] [Related]
13. Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide.
Lu J; Chew EH; Holmgren A
Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12288-93. PubMed ID: 17640917
[TBL] [Abstract][Full Text] [Related]
14. Effects of the antioxidant Pycnogenol on cellular redox systems in U1285 human lung carcinoma cells.
Gandin V; Nyström C; Rundlöf AK; Jönsson-Videsäter K; Schönlau F; Hörkkö J; Björnstedt M; Fernandes AP
FEBS J; 2009 Jan; 276(2):532-40. PubMed ID: 19077163
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds.
Witte AB; Anestål K; Jerremalm E; Ehrsson H; Arnér ES
Free Radic Biol Med; 2005 Sep; 39(5):696-703. PubMed ID: 16085187
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial thioredoxin reductase inhibition, selenium status, and Nrf-2 activation are determinant factors modulating the toxicity of mercury compounds.
Branco V; Godinho-Santos A; Gonçalves J; Lu J; Holmgren A; Carvalho C
Free Radic Biol Med; 2014 Aug; 73():95-105. PubMed ID: 24816296
[TBL] [Abstract][Full Text] [Related]
17. A new mechanism of action for the anticancer drug mitomycin C: mechanism-based inhibition of thioredoxin reductase.
Paz MM; Zhang X; Lu J; Holmgren A
Chem Res Toxicol; 2012 Jul; 25(7):1502-11. PubMed ID: 22694104
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of selenium compounds catalyzed by the mammalian selenoprotein thioredoxin reductase.
Lu J; Berndt C; Holmgren A
Biochim Biophys Acta; 2009 Nov; 1790(11):1513-9. PubMed ID: 19406206
[TBL] [Abstract][Full Text] [Related]
19. Selenite or selenomethionine interaction with methylmercury on uptake and toxicity showing a weak selenite protection: studies on cultured K-562 cells.
Frisk P; Yaqob A; Nilsson K; Lindh U
Biol Trace Elem Res; 2001 Jun; 80(3):251-68. PubMed ID: 11508630
[TBL] [Abstract][Full Text] [Related]
20. High-level expression in Escherichia coli of selenocysteine-containing rat thioredoxin reductase utilizing gene fusions with engineered bacterial-type SECIS elements and co-expression with the selA, selB and selC genes.
Arnér ES; Sarioglu H; Lottspeich F; Holmgren A; Böck A
J Mol Biol; 1999 Oct; 292(5):1003-16. PubMed ID: 10512699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
